Search Results - Debasish Sundi
- Showing 1 - 8 results of 8
-
1
-
2
-
3
-
4
-
5
Salvage lenvatinib/everolimus combination therapy after immune checkpoint inhibitor and VEGFR tyrosine kinase inhibitor for metastatic renal cell carcinoma by Christopher Kwok, Adam Khorasanchi, Sarah P. Psutka, Megan Hinkley, Shawn Dason, Debasish Sundi, Yuanquan Yang, Yajing Yang, Claire Verschraegen, Evan E. Gross, Delaney Orcutt, Ming Yin
Published in Frontiers in Oncology (2023-07-01)Get full text
Article -
6
Inhibition of urothelial carcinoma through targeted type I interferon-mediated immune activation by Devin Plote, Woonyoung Choi, Sharada Mokkapati, Debasish Sundi, James E Ferguson, Jon Duplisea, Nigel R. Parker, Seppo Yla-Herttuala, SUO CTC Bladder Committee, David McConkey, Kimberly S. Schluns, Colin P. Dinney
Published in OncoImmunology (2019-05-01)Get full text
Article -
7
Sex differences in bladder cancer: understanding biological and clinical implications by Prakash Chaudhary, Biplab Singha, Hany A. Abdel-Hafiz, Maria Velegraki, Debasish Sundi, Swati Satturwar, Anil V. Parwani, Sergei I. Grivennikov, Sungyong You, Helen S. Goodridge, Qin Ma, Yuzhou Chang, Anjun Ma, Bin Zheng, Dan Theodorescu, Zihai Li, Xue Li
Published in Biology of Sex Differences (2025-05-01)Get full text
Article -
8
Ensuring Successful Biomarker Studies in Bladder Preservation Clinical Trials for Non-muscle Invasive Bladder Cancer by David J. McConkey, Brian C. Baumann, Stephanie Cooper Greenberg, David J. DeGraff, Scott E. Delacroix, Jason A. Efstathiou, Jared Foster, Susan Groshen, Edward E. Kadel, Francesca Khani, William Y. Kim, Seth P. Lerner, Trevor Levin, Joseph C. Liao, Matthew I. Milowsky, Joshua J. Meeks, David T. Miyamoto, Kent W. Mouw, Eugene J. Pietzak, David B. Solit, Debasish Sundi, Abdul Tawab-Amiri, Pamela J. West, Sara E. Wobker, Alexander W. Wyatt, Andrea B. Apolo, Peter C. Black
Published in Bladder Cancer (2024-03-01)Get full text
Article
